Company Market News

Centessa Pharmaceuticals plc (NASDAQ: CNTA)
8:00 PM UTC, 06/20/25
Last: $12.43 Change: -0.25 %Change: -1.97% Volume: 1,612,616
Centessa Pharmaceuticals Posts Revenue, Q1 Net Loss Narrows

Back

Last updated: 05/14/2025 7:32:34 AM

07:32 AM EDT, 05/14/2025 (MT Newswires) -- Centessa Pharmaceuticals (CNTA) reported a Q1 net loss Wednesday of $0.20 per diluted share, narrower than a loss of $0.38 a year earlier.

Analysts polled by FactSet expected a loss of $0.33.

License and other revenue for the quarter ended March 31 was $15 million.

The company did not report any revenue a year earlier.

As of March 31, the company said it had $424.9 million in cash, cash equivalents and investments, expected to fund operations into mid-2027.

The company's shares were down 3.3% in recent Wednesday premarket activity.

http://www.mtnewswires.com
Copyright © 2025 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.




Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.